Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Richeldi

Showing results (191-200 of 356) with videos related to

Pageof 36
Sort By:
BMC Pulmonary Medicine|September 22, 2020
Mediastinal lymph node enlargement in idiopathic pulmonary fibrosis: relationships with disease progression and pulmonary function trendsGiacomo Sgalla, Anna Rita Larici, Nicoletta Golfi, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|October 23, 2020
Obstructive sleep apnea in sarcoidosis and impact of cpap treatment on fatiguePier-Valerio Mari, Giuliana Pasciuto, Matteo Siciliano, et al.
Current Neuropharmacology|December 31, 2020
The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative StressGanesh Raghu, Michael Berk, Peter A Campochiaro, et al.
AIDS (London, England)|July 11, 2003
MDR1 C3435T genetic polymorphism does not influence the response to antiretroviral therapy in drug-naive HIV-positive patientsMilena Nasi, Vanni Borghi, Marcello Pinti, et al.
Expert Opinion on Investigational Drugs|August 5, 2017
Investigational drugs for idiopathic pulmonary fibrosisFrancesco Varone, Giuliano Montemurro, Francesco Macagno, et al.
Nature Reviews. Disease Primers|October 21, 2017
Idiopathic pulmonary fibrosisFernando J Martinez, Harold R Collard, Annie Pardo, et al.
The Journal of Infection|December 26, 2006
Impact of a T cell-based blood test for tuberculosis infection on clinical decision-making in routine practiceSarah Gooding, Oni Chowdhury, Tim Hinks, et al.
Respiratory Medicine|February 27, 2016
Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS(®) trialsLuca Richeldi, Vincent Cottin, Roland M du Bois, et al.
Journal of Comparative Effectiveness Research|December 20, 2022
Plain language summary: Clinical study of BI 1015550 as a potential treatment for idiopathic pulmonary fibrosisLuca Richeldi, Arata Azuma, Vincent Cottin, et al.
Respiration; International Review of Thoracic Diseases|February 8, 2018
Statin Therapy and Outcomes in Trials of Nintedanib in Idiopathic Pulmonary FibrosisMichael Kreuter, Ulrich Costabel, Luca Richeldi, et al.
Pageof 36

Showing results (191-200 of 356) with videos related to

Sort By:
Pageof 36
BMC Pulmonary Medicine|September 22, 2020
Mediastinal lymph node enlargement in idiopathic pulmonary fibrosis: relationships with disease progression and pulmonary function trendsGiacomo Sgalla, Anna Rita Larici, Nicoletta Golfi, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|October 23, 2020
Obstructive sleep apnea in sarcoidosis and impact of cpap treatment on fatiguePier-Valerio Mari, Giuliana Pasciuto, Matteo Siciliano, et al.
Current Neuropharmacology|December 31, 2020
The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative StressGanesh Raghu, Michael Berk, Peter A Campochiaro, et al.
AIDS (London, England)|July 11, 2003
MDR1 C3435T genetic polymorphism does not influence the response to antiretroviral therapy in drug-naive HIV-positive patientsMilena Nasi, Vanni Borghi, Marcello Pinti, et al.
Expert Opinion on Investigational Drugs|August 5, 2017
Investigational drugs for idiopathic pulmonary fibrosisFrancesco Varone, Giuliano Montemurro, Francesco Macagno, et al.
Nature Reviews. Disease Primers|October 21, 2017
Idiopathic pulmonary fibrosisFernando J Martinez, Harold R Collard, Annie Pardo, et al.
The Journal of Infection|December 26, 2006
Impact of a T cell-based blood test for tuberculosis infection on clinical decision-making in routine practiceSarah Gooding, Oni Chowdhury, Tim Hinks, et al.
Respiratory Medicine|February 27, 2016
Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS(®) trialsLuca Richeldi, Vincent Cottin, Roland M du Bois, et al.
Journal of Comparative Effectiveness Research|December 20, 2022
Plain language summary: Clinical study of BI 1015550 as a potential treatment for idiopathic pulmonary fibrosisLuca Richeldi, Arata Azuma, Vincent Cottin, et al.
Respiration; International Review of Thoracic Diseases|February 8, 2018
Statin Therapy and Outcomes in Trials of Nintedanib in Idiopathic Pulmonary FibrosisMichael Kreuter, Ulrich Costabel, Luca Richeldi, et al.
Pageof 36